Cargando…
High Glucose Variability Increases Mortality Risk in Patients with COVID-19
BACKGROUND: In patients with COVID 19, with or without history of diabetes, having hyperglycemia is an important factor in mortality; approximately 45.2% of patients with this disease have elevated blood glucose levels. Glucose variability (GV) has also been shown to be an independent predictor of m...
Autores principales: | Guillermo, Arauz, Eduardo, Camey, Alejandra, Cárcamo, Grecia, Celis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556498/ http://dx.doi.org/10.1016/j.ahj.2021.10.028 |
Ejemplares similares
-
Is dyslipidemia associated to mortality in patients with COVID-19?
por: Grecia, Celis, et al.
Publicado: (2021) -
Cardio-metabolic factors associated to mortality in patients with COVID-19
por: Eduardo, Camey, et al.
Publicado: (2022) -
Glucose variability is a marker for COVID-19 severity and mortality
por: Abuhasira, Ran, et al.
Publicado: (2022) -
Increasing Blood Glucose Variability Is a Precursor of Sepsis and Mortality in Burned Patients
por: Pisarchik, Alexander N., et al.
Publicado: (2012) -
Spatial Variability in COVID-19 Mortality
por: Bossak, Brian H., et al.
Publicado: (2021)